II-8 Cell Surface Markers
Identification Assumes Critical Importance Amid Growing Prevalence of Chronic Diseases II-8 Cell Surface Markers
in Stem Cell Research II-9 Select Cell Surface Marker
s Used in Stem Cell Identification and Characterization.
This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker
testing in five European countries, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by country and market segment.
Cell surface marker
analysis is also essential in determination of experimental drug or ligand response.
In vitro assays, such as the efflux-based SP assay, ALDH activity assay, and cell surface marker
assays, have proven to be reproducible and straightforward methods of CSC detection.
Multiple myeloma cell lines and primary patient derived cells express the cell surface marker
Efalizumab is a recombinant humanized monoclonal antibody that binds to lymphocyte cell surface marker
CD11a, inhibiting the "activation and trafficking of T cells," according to Genentech Inc.
com/research/5xrkgm/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the European Cell Surface Marker
Testing Market: Supplier Shares, Competitive Intelligence, Emerging Opportunities" report to their offering.
During the next ten years, the main trend in cell surface marker
analysis will be further simplification of the sample preparation and the analysis itself.
com/research/p8bdp9/2015_us_cell) has announced the addition of the "2015 US Cell Surface Marker
Testing Market: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities" report to their offering.
ViroTect[R](VR)and ViroTect[R](Tropism) combine cell surface marker
detection of immune cells with molecular detection of HIV replication in a single assay with multiplexed protein and nucleic acid measurements.
Further investigational work is focusing on the use of this dual delivery approach directed against a tumor cell surface marker
to kill tumor cells directly plus an anti-angiogenic target that would impair a tumor's ability to grow by simultaneously reducing its blood supply.
The global cell surface marker
detection market is expected to reach USD 6.